ACTIVE

AERTS PHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

178 k €

-14.4% YoY

Gross margin

368,1 k €

-10.5% YoY

Equity

53,9 k €

+0.0% YoY

Workforce

1,6 ETP

0.0% YoY

What does AERTS PHARMA do?

AERTS PHARMA is a Private limited company incorporated in 2007. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Zonhoven. It employs on average 1,6 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0886.207.737

Incorporation

08/01/2007

Legal form

Private limited company

Registered office

Zavelstraat 22
3520 Zonhoven · FlandreSee on map

Contributed capital

12 400,00 €

Latest accounts

31/12/2025

Average workforce

1,6 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitablePositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007
Income statement
Gross margin	368,1 k €	-10.5%	411,4 k €	+20.0%	342,7 k €	+14.8%	298,5 k €	+3.5%	288,3 k €	+10.1%	262 k €	-5.7%	277,8 k €	-4.2%	289,9 k €	+9.1%	265,8 k €	-1.2%	269 k €	+7.1%	251,1 k €	+20.1%	209,1 k €	+4.2%	200,7 k €	-2.2%	205,3 k €	-0.4%	206,1 k €	+17.8%	174,9 k €	+2.4%	170,8 k €	+18.1%	144,6 k €	+11.0%	130,3 k €
EBITDA	263,7 k €	-13.4%	304,7 k €	+29.2%	235,9 k €	+20.6%	195,5 k €	+6.3%	184 k €	-0.4%	184,7 k €	-4.7%	193,9 k €	+1.3%	191,4 k €	+10.3%	173,6 k €	+0.1%	173,4 k €	+4.4%	166,2 k €	+17.8%	141,1 k €	+3.1%	136,8 k €	+3.1%	132,7 k €	-2.9%	136,7 k €	+25.9%	108,5 k €	+6.3%	102,1 k €	+98.4%	51,5 k €	+49.0%	34,6 k €
Operating result	208,1 k €	-16.4%	249 k €	+37.4%	181,3 k €	+27.9%	141,7 k €	+18.0%	120,1 k €	-0.6%	120,8 k €	-6.3%	128,8 k €	+2.6%	125,5 k €	+15.3%	108,8 k €	-10.0%	120,9 k €	+6.3%	113,7 k €	+28.7%	88,3 k €	+5.9%	83,4 k €	+5.6%	78,9 k €	-3.4%	81,7 k €	+49.6%	54,6 k €	+11.8%	48,8 k €	+348%	10,9 k €	+309%	-5,2 k €
Net result	178 k €	-14.4%	208 k €	+24.1%	167,6 k €	+32.5%	126,5 k €	+9.7%	115,4 k €	-1.5%	117,1 k €	-10.5%	130,9 k €	-1.5%	132,8 k €	+16.2%	114,3 k €	-5.3%	120,7 k €	+22.2%	98,8 k €	+24.6%	79,3 k €	+11.9%	70,8 k €	-5.5%	75 k €	+2.7%	73 k €	+85.3%	39,4 k €	-2.5%	40,4 k €	+279%	10,7 k €	+51887%	20,5 €
Balance sheet
Equity	53,9 k €	+0.0%	53,9 k €	+0.1%	53,8 k €	+0.3%	53,7 k €	+0.1%	53,7 k €	+0.1%	53,6 k €	+0.2%	53,5 k €	+0.7%	53,1 k €	+0.6%	52,8 k €	+120%	24 k €	+1.1%	23,7 k €	+1.2%	23,4 k €	+1.2%	23,1 k €	+267%	6,3 k €	+90.5%	3,3 k €	+1087%	278,8 €	+109%	-3,1 k €	-114%	23,1 k €	+85.9%	12,4 k €
Total assets	1 M €	+9.0%	956,8 k €	-0.5%	961,5 k €	+1.7%	945 k €	-0.8%	952,6 k €	-11.1%	1,1 M €	-2.4%	1,1 M €	-4.5%	1,1 M €	-2.8%	1,2 M €	+54.6%	764,1 k €	-0.7%	769,1 k €	-2.2%	786,2 k €	-6.8%	843,4 k €	-8.0%	916,8 k €	-5.7%	972,1 k €	-1.8%	990,1 k €	-2.4%	1 M €	+84.8%	549,1 k €	+0.4%	546,9 k €
Cash	261,8 k €	+105%	127,6 k €	-11.2%	143,7 k €	+28.2%	112 k €	+153%	44,3 k €	-43.7%	78,7 k €	+11.2%	70,8 k €	-13.5%	81,8 k €	+46.6%	55,8 k €	-23.5%	73 k €	+21.6%	60 k €	+66.7%	36 k €	-32.8%	53,5 k €	-16.6%	64,2 k €	-16.1%	76,5 k €	-11.2%	86,2 k €	-0.3%	86,4 k €	+0.8%	85,8 k €	+155%	33,6 k €
Debts	984,8 k €	+9.6%	898,3 k €	-0.5%	903,2 k €	+1.8%	886,9 k €	-0.7%	893 k €	-11.8%	1 M €	-2.5%	1 M €	-4.7%	1,1 M €	-2.7%	1,1 M €	+52.1%	735,5 k €	-1.0%	742,8 k €	-2.3%	760,4 k €	-7.0%	817,6 k €	-9.8%	906,8 k €	-6.1%	966 k €	-2.2%	987,3 k €	-2.6%	1 M €	+102%	502,4 k €	-5.3%	530,3 k €
Other
Workforce	1,6 ETP	0.0%	1,6 ETP	0.0%	1,6 ETP	-5.9%	1,7 ETP	0.0%	1,7 ETP	+41.7%	1,2 ETP	-29.4%	1,7 ETP	0.0%	1,7 ETP	0.0%	1,7 ETP	0.0%	1,7 ETP	+13.3%	1,5 ETP	+50.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	-9.1%	1,1 ETP	-26.7%	1,5 ETP	0.0%	1,5 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 12 ended

Active mandates

Apotheek Aerts Bart

Director · 0886.205.262

Represented by Bart Aerts

Active

Ended mandates

BVBA BVBA APOTHEEK AERTS BART

Manager · since 01 janvier 2014 · until 31 décembre 2014

Ended

BVBA BVBA APOTHEEK AERTS BART

Manager · since 01 janvier 2013 · until 31 décembre 2013

Ended

BVBA BVBA APOTHEEK AERTS BART

Manager · since 01 janvier 2012 · until 31 décembre 2012

Ended

BVBA BVBA APOTHEEK AERTS BART

Manager · since 01 janvier 2011 · until 31 décembre 2011

Ended

At this address

Other companies at this address

Company	CBE no.
Apotheek Aerts Bart● Active	0886.205.262

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	08/06/2026	05/06/2025	20/08/2024	11/08/2023	14/07/2022	05/08/2021
General meeting	02/06/2026	02/06/2025	03/06/2024	02/06/2023	02/06/2022	02/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	02/06/2026	08/06/2026	Dutch	PDF
Abridged model	31/12/2024	02/06/2025	05/06/2025	Dutch	PDF
Abridged model	31/12/2023	03/06/2024	20/08/2024	Dutch	PDF
Abridged model	31/12/2022	02/06/2023	11/08/2023	Dutch	PDF
Abridged model	31/12/2021	02/06/2022	14/07/2022	Dutch	PDF
Abridged model	31/12/2020	02/06/2021	05/08/2021	Dutch	PDF
Abridged model	31/12/2019	02/06/2020	03/09/2020	Dutch	PDF
Abridged model	31/12/2018	02/06/2019	22/08/2019	Dutch	PDF
Abridged model	31/12/2017	02/06/2018	08/08/2018	Dutch	PDF
Abridged model	31/12/2016	02/06/2017	08/08/2017	Dutch	PDF
Abridged model	31/12/2015	02/06/2016	29/06/2016	Dutch	PDF
Abridged model	31/12/2014	02/06/2015	06/07/2015	Dutch	PDF
Abridged model	31/12/2013	02/06/2014	26/06/2014	Dutch	PDF
Abridged model	31/12/2012	02/06/2013	08/08/2013	Dutch	PDF
Abridged model	31/12/2011	02/06/2012	08/08/2012	Dutch	PDF
Abridged model	31/12/2010	03/06/2011	22/06/2011	Dutch	PDF
Abridged model	31/12/2009	02/06/2010	05/07/2010	Dutch	PDF
Abridged model	31/12/2008	02/06/2009	23/06/2009	Dutch	PDF
Abridged model	31/12/2007	02/06/2008	11/06/2008	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 12 ended

Active mandates

Apotheek Aerts Bart

Director · 0886.205.262

Represented by Bart Aerts

Active

Ended mandates

BVBA BVBA APOTHEEK AERTS BART

Manager · since 01 janvier 2014 · until 31 décembre 2014

Ended

BVBA BVBA APOTHEEK AERTS BART

Manager · since 01 janvier 2013 · until 31 décembre 2013

Ended

BVBA BVBA APOTHEEK AERTS BART

Manager · since 01 janvier 2012 · until 31 décembre 2012

Ended

BVBA BVBA APOTHEEK AERTS BART

Manager · since 01 janvier 2011 · until 31 décembre 2011

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates23/06/2022
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DOEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates20/04/2009
BENAMING - ONTSLAGEN - BENOEMINGEN
PDF
Other16/01/2007
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025178 k €↓
2024
Annual accounts 2024208 k €↑
2023
Annual accounts 2023167,6 k €↑
2022
Annual accounts 2022126,5 k €↑
2022
Name changeAERTS PHARMA
2021
Annual accounts 2021115,4 k €↓
2021
Name changeAERTS PHARMA BV (EXPLOIT.)
2020
Annual accounts 2020117,1 k €↓
2019
Annual accounts 2019130,9 k €↓
2018
Annual accounts 2018132,8 k €↑
2017
Annual accounts 2017114,3 k €↓
2016
Annual accounts 2016120,7 k €↑
2015
Annual accounts 201598,8 k €↑
2014
Annual accounts 201479,3 k €↑
2013
Annual accounts 201370,8 k €↓
2012
Annual accounts 201275 k €↑
2011
Annual accounts 201173 k €↑
2010
Annual accounts 201039,4 k €↓
2009
Annual accounts 200940,4 k €↑
2008
Annual accounts 200810,7 k €↑
2007
Annual accounts 200720,5 €
08/01/2007
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

AERTS PHARMA

Overview

What does AERTS PHARMA do?

Trend over 19 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline